-
Business Wire via Yahoo! Finance - Wed Dec 9, 8:00 am ET
CARLSBAD, Calif.----Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. , and Isis Pharmaceuticals, Inc. , unveiled plans for an educational webinar about microRNA biology that will highlight several recent exciting discoveries in the field and showcase the therapeutic strategies based on microRNA.
-
Business Wire via Yahoo! Finance - Wed Dec 9, 7:30 am ET
OCEANSIDE, Calif.----Lifeline Skin Care, Inc, a wholly owned subsidiary of International Stem Cell Corporation , www.internationalstemcell.com, announced today that it has retained the services of a highly experienced expert in the skin care industry, Raulee Marcus, to help design a marketing program for its newly created line of skin care products based on ISCO’s ...
-
Business Wire via Yahoo! Finance - Wed Dec 9, 7:00 am ET
DUBLIN----Research and Markets has announced the addition of GlobalData 's new report "Crohn's Disease - Drug Pipeline Analysis and Market Forecasts to 2015" to their offering.
-
BioresearchOnline - Wed Dec 9, 5:12 am ET
The skin is known for its ability to regenerate because the cells in the skin are constantly turning over. This "healing property" has attracted much attention from scientists wanting to know what makes the skin repair itself.
-
BioresearchOnline - Wed Dec 9, 5:12 am ET
Stimulating the growth of new neurons to replace those lost in Alzheimer's disease (AD) is an intriguing therapeutic possibility. But will the factors that cause AD allow the new neurons to thrive and function normally? Scientists at the Gladstone Institute of Neurological Disease (GIND) have discovered that two main causes of AD amyloid-beta (Aß) peptides and apolipoprotein E4 (apoE4) impair ...
-
WILX 10 Lansing - Wed Dec 9, 5:08 am ET
MI stem cell research regulations to get hearing
-
The Wheaton Sun - Wed Dec 9, 5:01 am ET
It can be difficult enough for a couple to make the decision to pursue in vitro fertilization. Years of frustration with infertility problems, financial considerations, advancing age, and many other issues factor in to the decision of whether or not to go for in vitro, or IVF.
-
PRWeb - Wed Dec 9, 4:15 am ET
Helping Corporations Use Social Media Tools, Sites and Applications to Connect With Customers and Prospects (PRWeb Dec 9, 2009) Read the full story at http://www.prweb.com/releases/HorizonConnect/HorizonMarketing/prweb3311724.htm
-
Douglas County News-Press - Thu Dec 10, 1:57 am ET
Highlands Ranch resident Allison Atkinson Adams and her sister Whitney, lost their two siblings to Fanconi Anemia and now the family dedicates themselves to spread awareness and raise funds to help find a cure.
-
KDKA Pittsburgh - Wed Dec 9, 9:53 pm ET
Cardiologists at Allegheny General Hospital are participating in a study that is examining the use of adult stem cells from donated blood marrow as treatment for heart attack patients.
-
WZZM 13 Grand Rapids - Wed Dec 9, 8:58 pm ET
A state Senate committee could vote soon on legislation regulating stem cell research in Michigan.
-
Investor's Business Daily via Yahoo! Finance - Wed Dec 9, 6:29 pm ET
Industry newcomer FaithShares Trust released its first three ETFS targeting Christians:
-
San Francisco Chronicle - Wed Dec 9, 5:45 pm ET
Once Mission Bay was a crescent-shaped cove that was part of San Francisco Bay, and Mission Creek - a hefty stream that flowed from its headwaters in the San Miguel Hills (including Twin Peaks) - meandered through the Mission District, and emptied into the... Mission District San Francisco California - San Francisco Bay - Twin Peaks - California - United States
-
The Chelsea Standard - Wed Dec 9, 5:40 pm ET
For the Chelsea Standard ‘Around Town with Linda’ “Around Town with Linda” will feature Tom Clemons, owner of Chelsea Village Hardware, beginning today. “Around Town with Linda” features interviews conducted by the local host Linda Meloche.
-
UPI - Wed Dec 9, 5:28 pm ET
HOUSTON, Dec. 9 (UPI) -- Scientists at the University of Texas Medical School at Houston say they've started a Phase II trial of a new stem cell-based therapy for injured heart muscle.